EUVIMEDEUVIMED entdecken
Crossref

Si-Ni-San inhibits hepatic Fasn expression and lipid accumulation in MAFLD mice through AMPK/p300/SREBP-1c axis

Tian Lan, Xiao-Juan Geng, Si-Jia Zhang, Xi-Xi Zeng, Jun-Jie Ying, Yi Xu, Shi-Yu Liu, Ping Li, Yu-Hua Tong, Wen Wang, Zhu-Jun Mao, Si-Wei Wang

Phytomedicine · 2024-01 · 123 · 155209

DOI: 10.1016/j.phymed.2023.155209 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2024-01. Verfasst von Tian Lan und 11 weiteren Autor:innen. Beteiligte Einrichtung: The Joint Innovation Center for Health & Medicine, the Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou 324…. Hauptthemen laut MEDLINE: AMP-Activated Protein Kinases, Non-alcoholic Fatty Liver Disease, Drugs, Chinese Herbal. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Zhejiang Province Natural Science Foundation, Quzhou Municipal Science and Technology Bureau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Soothing the liver and regulating qi is one of the core ideas of traditional Chinese medicine (TCM) in the treatment of fatty liver. Si-Ni-San (SNS) is a well-known herbal formula in TCM for liver soothing and qi regulation in fatty liver treatment. However, its efficacy lacks modern scientific evidence. PURPOSE: This study was aimed to investigate the impact of SNS on metabolic associated fatty liver disease (MAFLD) in mice and explore the underlying molecular mechanisms, particularly its effects on lipid metabolism in hepatocytes. METHODS: The therapeutic effect of SNS was evaluated using in vivo and in vitro models of high-fat/high-cholesterol (HFHC) diet-induced mice and palmitic acid (PA)-induced hepatocytes, respectively. Molecular biological techniques such as RNA-sequencing (RNA-seq), co-immunoprecipitation (co-IP), and western blotting were employed to elucidate the molecular mechanism of SNS in regulating lipid metabolism in hepatocytes. RESULTS: Our findings revealed that SNS effectively reduced lipid accumulation in the livers of HFHC diet-induced mice and PA-induced hepatocytes. RNA-seq analysis demonstrated that SNS significantly down-regulated the expression of fatty acid synthase (Fasn) in the livers of HFHC-fed mice. Mechanistically, SNS inhibited Fasn expression and lipid accumulation by activating adenosine monophosphate (AMP)-activated protein kinase (AMPK). Activation of AMPK suppressed the activity of the transcriptional coactivator p300 and modulated the protein stability of sterol regulatory element-binding protein-1c (SREBP-1c). Importantly, p300 was required for the inhibition of Fasn expression and lipid accumulation by SNS. Furthermore, SNS activated AMPK by decreasing adenosine triphosphate (ATP) production in hepatocytes. CONCLUSION: This study provided novel evidence on the regulatory mechanisms underlying the effects of SNS on Fasn expression. Our findings demonstrate, for the first time, that SNS exerts suppressive effects on Fasn expression through modulation of the AMPK/p300/SREBP-1c axis. Consequently, this regulatory pathway mitigates excessive lipid accumulation and ameliorates MAFLD in mice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AMP-Activated Protein KinasesNon-alcoholic Fatty Liver DiseaseDrugs, Chinese HerbalMiceAnimalsSterol Regulatory Element Binding Protein 1LiverLipid MetabolismFatty Acid SynthasesCholesterolProtein Stability

Stichwörter der Autor:innen

AMPKFASNSREBP-1cSi-Ni-Sanlipid accumulationp300

Substanzen

shigyaku-sanAMP-Activated Protein KinasesSterol Regulatory Element Binding Protein 1Fatty Acid SynthasesCholesterolDrugs, Chinese Herbal

Autor:innen und Institutionen

  • The Joint Innovation Center for Health & Medicine, the Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou 324000, China.
  • College of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China.
  • The Joint Innovation Center for Health & Medicine, the Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou 324000, China; Department of Ophthalmology, The Quzhou Affiliated Hospita…
  • Preventive Treatment Center, Zhejiang Chinese Medical University Affiliated Four-provinces Marginal Hospital of Traditional Chinese Medicine, Quzhou Hospital of Traditional Chinese Medicine, Quzhou 324000, China. Electr…
  • College of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China; Department of Ophthalmology, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzho…
  • The Joint Innovation Center for Health & Medicine, the Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou 324000, China. Electronic address: wsw_1972@wmu.edu.cn.

Förderung

  • Zhejiang Province Natural Science Foundation
  • Quzhou Municipal Science and Technology Bureau

Zitieren

APA

Lan, T., Geng, X. J., Zhang, S. J., Zeng, X. X., Ying, J. J., Xu, Y., Liu, S. Y., Li, P., Tong, Y. H., Wang, W., Mao, Z. J., & Wang, S. W. (2024). Si-Ni-San inhibits hepatic Fasn expression and lipid accumulation in MAFLD mice through AMPK/p300/SREBP-1c axis. Phytomedicine, 123, 155209. https://doi.org/10.1016/j.phymed.2023.155209

Vancouver

Lan T, Geng XJ, Zhang SJ, Zeng XX, Ying JJ, Xu Y, et al. Si-Ni-San inhibits hepatic Fasn expression and lipid accumulation in MAFLD mice through AMPK/p300/SREBP-1c axis. Phytomedicine. 2024;123:155209. doi:10.1016/j.phymed.2023.155209

BibTeX
@article{Lan2024,
  author = {Lan, Tian and Geng, Xiao-Juan and Zhang, Si-Jia and Zeng, Xi-Xi and Ying, Jun-Jie and Xu, Yi and Liu, Shi-Yu and Li, Ping and Tong, Yu-Hua and Wang, Wen and Mao, Zhu-Jun and Wang, Si-Wei},
  title = {Si-Ni-San inhibits hepatic Fasn expression and lipid accumulation in MAFLD mice through AMPK/p300/SREBP-1c axis},
  journal = {Phytomedicine},
  year = {2024},
  volume = {123},
  pages = {155209},
  doi = {10.1016/j.phymed.2023.155209}
}
Kostenlos starten →